Boston Scientific AGENT Drug-Coated Balloon Lands Long-Awaited FDA Approval
CardiacWire
MARCH 2, 2024
The United States has been way behind other nations in using drug-coated balloons (DCB) to treat coronary in-stent restenosis (ISR), but that’s about to change thanks to the FDA approval of Boston Scientific’s AGENT Drug-Coated Balloon. vs 12.3%) Stent thrombosis (0.0% vs 12.3%) Stent thrombosis (0.0%
Let's personalize your content